
浏览全部资源
扫码关注微信
1.重庆两江新区第一人民医院神经内科,重庆 401121
2.重庆医科大学附属第一医院神经内科,重庆 400016
戴 瑶,Email:335263217@qq.com, 研究方向:神经病学。
杨 琴,Email:xyqh200@126.com。
收稿:2021-11-22,
修回:2022-02-28,
录用:2022-03-16,
纸质出版:2023-05-28
移动端阅览
戴瑶,杨琴.肿瘤样脱髓鞘病变报道3例[J].重庆医科大学学报,2023,48(5):614-617.
Dai Yao,Yang Qin.Three cases report of tumefactive demyelinating lesions[J].Journal of Chongqing Medical University,2023,48(5):614-617.
戴瑶,杨琴.肿瘤样脱髓鞘病变报道3例[J].重庆医科大学学报,2023,48(5):614-617. DOI: 10.13406/j.cnki.cyxb.003183.
Dai Yao,Yang Qin.Three cases report of tumefactive demyelinating lesions[J].Journal of Chongqing Medical University,2023,48(5):614-617. DOI: 10.13406/j.cnki.cyxb.003183.
Balloy G , Pelletier J , Suchet L , et al . Inaugural tumor-like multiple sclerosis:clinical presentation and medium-term outcome in 87 patients [J ] . J Neurol , 2018 , 265 ( 10 ): 2251 - 2259 .
Kumar S , Datta AK , Chakraborty U , et al . Tumefactive demyelination:a clinico-radiological dilemma [J ] . J R Coll Physicians Edinb , 2021 , 51 ( 3 ): 278 - 280 .
Sindic CJ , van Antwerpen MP , Goffette S . The intrathecal humoral immune response:laboratory analysis and clinical relevance [J ] . Clin Chem Lab Med , 2001 , 39 ( 4 ): 333 - 340 .
Altintas A , Petek B , Isik N , et al . Clinical and radiological characteristics of tumefactive demyelinating lesions:follow-up study [J ] . Mult Scler , 2012 , 18 ( 10 ): 1448 - 1453 .
Hyland M , Bermel RA , Cohen JA . Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions [J ] . Neurol Clin Pract , 2013 , 3 ( 1 ): 15 - 21 .
戚晓昆 . 应重视中枢神经系统炎性脱髓鞘病的相关问题 [J ] . 中华医学杂志 , 2012 , 92 ( 43 ): 3025 - 3027 .
Qi XK . Focus on problems of central nervous system inflammatory demyelinating disease [J ] . Natl Med J China , 2012 , 92 ( 43 ): 3025 - 3027 .
Paoletti M , Muzic SI , Marchetti F , et al . Differential imaging of atypical demyelinating lesions of the central nervous system [J ] . Radiol Med , 2021 , 126 ( 6 ): 827 - 842 .
Low CK , Lim WEH , Rumpel H . Differentiating tumefactive demyelinating lesion from neoplasm-does physiologic MR imaging help? [J ] . Radiography , 2011 , 17 ( 1 ): 76 - 80 .
Barbagallo M , Albatly AA , Schreiner S , et al . Value of 18 F-FET PET in patients with suspected tumefactive demyelinating disease:preliminary experience from a retrospective analysis [J ] . Clin Nucl Med , 2018 , 43 ( 11 ): e385 - e391 .
Nakajima A , Kawachi I . Tumefactive demyelinating lesion (TDL) [J ] . No Shinkei Geka , 2021 , 49 ( 2 ): 376 - 382 .
Siffrin V , Müller-Forell W , von Pein H , et al . How to treat tumefactive demyelinating disease? [J ] . Mult Scler , 2014 , 20 ( 5 ): 631 - 633 .
Balloy G , Pelletier J , Suchet L , et al . Inaugural tumor-like multiple sclerosis:clinical presentation and medium-term outcome in 87 patients [J ] . J Neurol , 2018 , 265 ( 10 ): 2251 - 2259 .
Yiu EM , Laughlin S , Verhey LH , et al . Clinical and magnetic resonance imaging(MRI) distinctions between tumefactive demyelination and brain tumors in children [J ] . J Child Neurol , 2014 , 29 ( 5 ): 654 - 665 .
Algahtani H , Shirah B , Alassiri A . Tumefactive demyelinating lesions:a comprehensive review [J ] . Mult Scler Relat Disord , 2017 , 14 : 72 - 79 .
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621